The representatives of pharmaceutical companies have been assured by Government officials that drug prices will be raised in keeping with the jump in manufacturing costs over past years.
This surety was given on Tuesday, by officials of the Drug Regulatory Authority of Pakistan (DRAP) to office-bearers of the Pharmaceutical Manufacturers Association (PPMA).
An increase in drug prices has been made clear to the Pharma industry by Government officials.— Healthwire News (@HealthwireNews) March 15, 2023
.#medicine #government #Health #TrendingNow #Pharma #price #BreakingNews #HealthwireNews
The Pharma Bureau represents multinational pharmaceutical companies while the PPMA is an umbrella body for local firms.
A joint commission of the two organizations held meetings at the offices of DRAP and the Special Health Secretary in Islamabad and informed them of the information. It was informed that a number of medicines were already unavailable, and the entire pharma sector was in danger of running out of stock if the industry’s problems were not managed urgently.
A member of the Central Executive Committee (CEC) of PPMa, told a private news channel that, “we informed the Special Health Secretary Nasiruddin Mashhood and the Chief Executive Officer (CEO) of Drap, Dr. Asim Rauf, about the depleted stocks of raw materials and finished products. We said the industry is on the verge of collapse as some companies are already out of stock while others will exhaust their raw material within a few weeks.”
There was another meeting held between the delegation and Minister of Health Services Abdul Qadir Patel and Finance Minister Ishaq Dar later.
Dar assured that the matter will be handled at a meeting of the policy board on March 24. On the other hand, Mr. Patel said “his ministry will take steps to ensure an uninterrupted supply of medicines.”
The government is trying its best to address the issues of the common man despite various economic challenges. Several meetings are being conducted to resolve this issue as soon as it can be.